Manuscripts
Showing 1592 manuscripts.
Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial
Citation
Patricia Mandima, Kristin Baltrusaitis, Grace Montepiedra, Lisa Aaron, Jyoti Mathad, Carolyne Onyango-Makumbi, Mandisa Nyati, James Ngocho, Gift Chareka, Ponego Ponatshego, Gaerolwe Masheto, Katie McCarthy, Patrick Jean-Philippe, Amita Gupta, Lynda Stranix-Chibanda, IMPAACT P1078 TB APPRISE study team. Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial. Journal of Acquired Immune Deficiency Syndromes. 2023 Jan 17; PMID: 36650479; PMCID: PMC9847058.Year
2023
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1078
Markers of intestinal immune activation and inflammation are not associated with preterm birth among women with low level HIV viremia
Citation
Anna Maya Powell, Deborah Persaud, Jean Rene Anderson, Deborah Kacanek, Yanling Huo, Kevin Psoter, Lisa R Yanek, Khalil Ghanem, Irina Burd, International Maternal Pediatric Adolescent AIDS Clinical Trial (IMPAACT) 1025 protocol team. Markers of intestinal immune activation and inflammation are not associated with preterm birth among women with low level HIV viremia. American Journal of Reproductive Immunology. 2023 Apr 14; PMID: 36680487; PMCID: PMC10026076.Year
2023
Journal
American Journal of Reproductive Immunology
Study
P1025
Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants
Citation
Ashenafi S. Cherkos, Sylvia M. LaCourse, Daniel A. Enquobahrie, Barbra A. Richardson, Sarah Bradford, Grace Montepiedra, Blandina T. Mmbaga, Tapiwa Mbengeranwa, Gaerolwe Masheto, Patrick Jean–Phillippe, Nahida Chakhtoura, Gerhard Theron, Adriana Weinberg, Haseena Cassim, Mpho S. Raesi, Elsie Jean, Deo Wabwire, Teacler Nematadzira, Lynda Stranix-Chibanda, Anneke C. Hesseling, Linda Aurpibul, Tapiwa Mbengeranwa, Amita Gupta, Grace John-Stewart, IMPAACT P1078 TB APPRISE Study Team. Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants. 2023 Mar 17; PMID: 36969345; PMCID: 10031034.Year
2023
HIV-1 Remission and Possible Cure in a Woman after Haplo-Cord Blood Transplant
Citation
Jingmei Hsu, Koen Van Besien, Marshall J. Glesby, Savita Pahwa, Anne Coletti, Meredith G. Warshaw, Lawrence D Petz, Theodore B. Moore, Ya Hui Chen, Suresh Pallikkuth, Adit Dhummakupt, Ruth Cortado, Amanda Golner, Frederic Bone, Maria Baldo, Marcie Riches, John W. Mellors, Nicole H. Tobin, Renee Browning, Deborah Persaud, Yvonne Bryson, IMPAACT P1107 Team. HIV-1 Remission and Possible Cure in a Woman after Haplo-Cord Blood Transplant. Cell. 2023 Mar 16; 186(6):1115-1126.Year
2023
Journal
Cell
Study
P1107
Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial
Citation
Ashenafi S Cherkos, Sylvia M LaCourse, Daniel A Enquobahrie, Barbra A Richardson, Sarah Bradford, Grace Montepiedra, Blandina T Mmbaga, Tapiwa Mbengeranwa, Gaerolwe Masheto, Patrick Jean-Phillippe, Nahida Chakhtoura, Gerhard Theron, Adriana Weinberg, Haseena Cassim, Mpho S Raesi, Elsie Jean, Deo Wabwire, Teacler Nematadzira, Lynda Stranix-Chibanda, Anneke C Hesseling, Linda Aurpibul, Amita Gupta, Grace John-Stewart, IMPAACT P1078 TB APPRISE Study Team. Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial. eClinicalMedicine. 2023 Apr 01; 58:101912. PMID: 36969345; PMCID: PMC10031034.Year
2023
Journal
eClinicalMedicine
Study
P1078
Progesterone and prolactin levels in pregnant women living with HIV who delivered preterm and low birthweight infants: A nested case-control study
Citation
Benjamin H. Chi, Dorothy Sebikari, Sean S. Brummel, Patricia DeMarrais, Rachel Chamanga, Maxensia Owor, Sufia Dadabhai, Joan T. Price, Taha Taha, Jeffrey Stringer, Mary Glenn Fowler. Progesterone and prolactin levels in pregnant women living with HIV who delivered preterm and low birthweight infants: A nested case-control study. PLoS One. 2023 Jan 23; 18(1):e0280730. PMID: 36689442; PMCID: PMC9870101.Year
2023
Journal
PLoS One
Study
1077BF, 1077FF
The cascade of care for household contacts of people with drug-resistant TB
Citation
Isabella Gomes, Tushar Garg, Gavin Churchyard, Amita Gupta, Anneke C Hesseling, Susan Swindells, Wilfred Gurupira, Bruno Martel, Lungile Mbata, Sandesh Patil, Cynthia Riviere, Mariecef Tonquin, David Dowdy, Hojoon Sohn. The cascade of care for household contacts of people with drug-resistant TB. International Journal of Tuberculosis and Lung Disease. 2023 Feb 01; 27(2):154-156. PMID: 36853100; PMCID: PMC10115168.Year
2023
Journal
International Journal of Tuberculosis and Lung Disease
Study
IMPAACT 2003/ACTG 5300
Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household
Citation
Soyeon Kim, Anneke C Hesseling, Xingye Wu, Michael D Hughes, N Sarita Shah, Sanjay Gaikwad, Nishi Kumarasamy, Erika Mitchell, Mey Leon, Pedro Gonzales, Sharlaa Badal-Faesen, Madeleine Lourens, Sandy Nerette, Justin Shenje, Petra de Koker, Supalert Nedsuwan, Lerato Mohapi, Unoda A Chakalisa, Rosie Mngqbisa, Rodrigo Otávio da Silva Escada, Samuel Ouma, Barbara Heckman, Linda Naini, Amita Gupta, Susan Swindells, Gavin Churchyard, ACTG A5300/IMPAACT 2003 PHOENIx Feasibility Study Team. Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household. PLoS One. 2023 Mar 17; 18(3):e0283290. PMID: 36930628; PMCID: PMC10022776.Year
2023
Journal
PLoS One
Study
IMPAACT 2003/ACTG 5300
Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial
Citation
Lameck Chinula, Lauren Ziemba, Sean Brummel, Katie McCarthy, Anne Coletti, Chelsea Krotje, Benjamin Johnston, Kevin Knowles, Sikhulile Moyo, Lynda Stranix-Chibanda, Risa Hoffman, Paul E Sax, Jeffrey Stringer, Nahida Chakhtoura, Patrick Jean-Philippe, Violet Korutaro, Haseena Cassim, Lee Fairlie, Gaerolwe Masheto, Ceejay Boyce, Lisa M Frenkel, K Rivet Amico, Lynette Purdue, Roger Shapiro, Blandina Theophil Mmbaga, Faeezah Patel, Jean van Wyk, James F Rooney, Judith S Currier, Shahin Lockman, IMPAACT 2010/VESTED Study Team and Investigators. Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet HIV. 2023 May 08; S2352-3018(23):00061-9. PMID: 37167996; PMCID: PMC10280394.Year
2023
Journal
Lancet HIV
Study
IMPAACT 2010
A Per-Protocol Analysis using Inverse Probability of Censoring Weights in a Randomized Trial of Initial PI versus NNRTI Regimens in Children
Citation
Dwight E. Yin, Stephen R. Cole, Christina Ludema, M. Alan Brookhart, Carol E. Golin, William C. Miller, Ross E. McKinney, Jr. A Per-Protocol Analysis using Inverse Probability of Censoring Weights in a Randomized Trial of Initial PI versus NNRTI Regimens in Children. American Journal Of Epidemiology. 2023 Jun 02; 192(6):916-928. PMID: 36896583.Year
2023
Journal
American Journal Of Epidemiology